Influenza vaccine delivery and effectiveness in end-stage renal disease

Kidney International

Volumn 63, Issue 2, 2003, Pages 738-743

  Gilbertson, David T ^a,b,c,d,e   Unruh, Mark ^a,b,c,d   McBean, A Marshall ^a,b,c,d   Kausz, Annamaria T ^a,b,c,d   Snyder, Jon J ^a,b,c,d   Collins, Allan J ^a,b,c,d  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e United States Renal Data System   (United States)

Author keywords

Hemodialysis; Hospitalizations; Immunization; Influenza; Mortality and vaccination; Peritoneal dialysis; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VIRUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

EID: 0037251531     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00787.x     Document Type: Article

References (35)

1. SIMONSEN L, CLARKE MJ, WILLIAMSON GD, et al: The impact of influenza epidemics on mortality: Introducing a severity index. Am J Public Health 87:1944-1950, 1997
2. SARNAK MJ, JABER BL: Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120:1883-1887, 2001
3. GROSS PA, HERMOGENES AW, SACKS HS, et al: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123:518-527, 1995
4. NICHOL KL, BAKEN L, NELSON A: Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130:397-403, 1999
5. NICHOL KL, MARGOLIS KL, WUORENMA J, et al: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 331:778-784, 1994
6. NICHOL KL, WUORENMA J, VON STERNBERG T: Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 158:1769-1776, 1998
7. FOSTER DA, TALSMA A, FURUMOTO-DAWSON A, et al: Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 136:296-307, 1992
8. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES: Healthy People 2010 (2nd ed). Washington, DC, U.S. Government Printing Office, 2000
9. Influenza and pneumococcal vaccination levels among persons aged 3 or 3 65 years-United States, 1999. MMWR Morb Mortal Wkly Rep 50:532-537, 2001
10. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 47:1-26, 1998
11. CHATENOUD L, HERBELIN A, BEAURAIN G, et al: Immune deficiency of the uremic patient. Adv Nephrol Necker Hosp 19:259-274, 1990
12. ORTBALS DW, MARKS ES, LIEBHABER H: Influenza immunization in patients with chronic renal disease. JAMA 239:2562-2565, 1978
13. Update: Influenza activity-United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine. MMWR Morb Mortal Wkly Rep 47:280-284, 1998
14. Update: Influenza activity-United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine. MMWR Morb Mortal Wkly Rep 48:374-378, 1999
15. Physician's Current Procedural Terminology 4. Chicago, American Medical Association, 1996
16. CHARLSON ME, POMPEI P, ALES KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
17. DEYO RA, CHERKIN DC, CIOL MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
18. INTERNATIONAL CLASSIFICATION OF DISEASES, 9th Revision, Clinical Modification (ICD-9-CM). Washington, DC, Health Care Financing Administration, 1998
19. BEDDHU S, BRUNS FJ, SAUL M, et al: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108:609-613, 2000
20. US RENAL DATA SYSTEM: USRDS 2000 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
21. US RENAL DATA SYSTEM: USRDS 2001 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001
22. KIEFE CI, ALLISON JJ, WILLIAMS OD, et al: Improving quality improvement using achievable benchmarks for physician feedback: A randomized controlled trial. JAMA 285:2871-2879, 2001
23. CENTERS FOR MEDICARE AND MEDICAID SERVICES: 2001 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore, Department of Health and Human Services, Centers for Medicare and Medicaid Services, Center for Beneficiary Choices, 2001
24. CHIN MH, ZHANG JX, MERRELL K: Diabetes in the African-American Medicare population. Morbidity, quality of care, and resource utilization. Diabetes Care 21:1090-1095, 1998
25. SCHNEIDER EC, CLEARY PD, ZASLAVSKY AM, et al: Racial disparity in influenza vaccination: Does managed care narrow the gap between African Americans and whites? JAMA 286:1455-1460, 2001
26. GIACOMINI MK: Gender and ethnic differences in hospital-based procedure utilization in California. Arch Intern Med 156:1217-1224, 1996
27. DAUMIT GL, HERMANN JA, CORESH J, et al: Use of cardiovascular procedures among black persons and white persons: A 7-year nationwide study in patients with renal disease. Ann Intern Med 130: 173-182, 1999
28. OZMINKOWSKI RJ, WHITE AJ, HASSOL A, et al: Minimizing racial disparity regarding receipt of a cadaver kidney transplant. Am J Kidney Dis 30:749-759, 1997
29. ODDONE EZ, HORNER RD, DIERS T, et al: Understanding racial variation in the use of carotid endarterectomy: The role of aversion to surgery. J Natl Med Assoc 90:25-33, 1998
30. HORNER RD, ODDONE EZ, MATCHAR DB: Theories explaining racial differences in the utilization of diagnostic and therapeutic procedures for cerebrovascular disease. Milbank Q 73:443-462, 1995
31. GURFINKEL EP, DE LA FUENTE RL, MENDIZ O, et al: Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105:2143-2147, 2002
32. NAGHAVI M, BARLAS Z, SIADATY S, et al: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulatopm 102:3039-3045, 2000
33. NEUZIL KM, REED GW, MITCHEL EF JR, et al: Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 281:901-907, 1999
34. ANTONEN JA, HANNULA PM, PYHALA R, et al: Adequate sero-response to influenza vaccination in dialysis patients. Nephron 86:56-61, 2000
35. RODGERS DJ, KARP SK, WOODRUFF SD, et al: Influenza immunization rates in the Intermountain End-Stage Renal Disease Network (Network 15). Adv Ren Replace Ther 7(Suppl):S81-S84, 2000